Artificial intelligence is being used to develop cancer vaccines in Oxford

Scientists at Oxford University are using a supercomputer based on artificial intelligence to develop vaccines against cancer. This was reported by Zamin.uz.

The supercomputer named “Dawn” allows the team to work for 10,000 hours. This system helps to quickly and accurately analyze patient data and identify their interconnections.

The researchers aim to include the obtained results in the Oxford Neoantigen Atlas to further advance cancer vaccine research in the United Kingdom. According to the scientists, the results achieved with the help of the supercomputer will not only accelerate vaccine development but also open new opportunities for treating cancer and other serious diseases in the future.

This technology is a major breakthrough in medicine, creating hopeful prospects for patients. Additionally, AI-based solutions help make the healthcare system more efficient.

During the research, it is planned to expand and improve these methods. As a result, a new era in the fight against cancer is expected to begin.

This holds significant importance for the global healthcare system.